Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00691405

Public ClinicalTrials.gov record NCT00691405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Multicenter, Two-part Parallel-group, Dose-ranging Study of Twice-daily and Once-daily (R,R) Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A dose ranging study to evaluate the safety, tolerability and efficacy of arformoterol (given once or twice a day) in subjects with COPD.

Study identification

NCT ID
NCT00691405
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
215 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2003 (Type not available)
Primary completion
May 2004 (Actual)
Completion
May 2004 (Actual)
Last update posted
Feb 22, 2012

2003 – 2004

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Not listed Encinitas California — —
Not listed Long Beach California — —
Not listed Brandon Florida — —
Not listed Cleawater Florida — —
Not listed Fort Lauderdale Florida — —
Not listed Jacksonville Florida — —
Not listed Port Orange Florida — —
Not listed West Palm Beach Florida — —
Not listed Austell Georgia — —
Not listed Topeka Kansas — —
Not listed Marrero Louisiana — —
Not listed New Orleans Louisiana — —
Not listed Opelousas Louisiana — —
Not listed McCook Nebraska — —
Not listed Princeton New Jersey — —
Not listed Hickory North Carolina — —
Not listed Statesville North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Columbus Ohio — —
Not listed Eugene Oregon — —
Not listed Medford Oregon — —
Not listed Pittsburgh Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Columbia South Carolina — —
Not listed Simpsonville South Carolina — —
Not listed Spartanburg South Carolina — —
Not listed Austin Texas — —
Not listed San Antonio Texas — —
Not listed Renton Washington — —
Not listed Spokane Washington — —
Not listed Tacoma Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00691405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2012 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00691405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →